ArticleFrontiers in pharmacology2017

Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.

Victor Brito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.